Release Date: 02/03/10 17:08 Summary: Supplementary Prospectus Price Sensitive: Yes Download Document 132.33KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling